This study investigates the use of 68Ga-PFA2 PET imaging for diagnosing tumors that are positive for Annexin A2.
The study evaluates the potential of 68Ga-PFA2 PET imaging as a non-invasive method for early detection of tumor invasion and metastasis, focusing on its effectiveness in identifying Annexin A2-positive tumors.
- Who can participate: Adults aged 18 to 80 years with confirmed lung cancer who are scheduled for a biopsy or surgery within two months can participate. Participants must understand the study and consent to it, and be able to complete examinations independently.
- Study details: Participants will undergo 68Ga-PFA2 PET imaging to evaluate tumor characteristics. This imaging method is non-invasive and focuses on Annexin A2.